Rocket Lab's roughly $80 billion valuation, including its newly announced $3 billion dilution, would require $3-4 billion in profit to be reasonable, and there is no scenario where it earns $3 billion within three years. The market can stay illogical longer than expected, so it could still run 50% before crashing 80%; the same applies to AST SpaceMobile. x.com  x.com 

Iridium's L-band spectrum, PNT and acquired Aireon still have substantial value, despite stalled growth and rising leverage. Third-quarter revenue rose 8% to $245.7 million and subscribers grew 6%; reported net income nearly tripled to $106.9 million, with the attached results attributing much of that gain to the Aireon acquisition. x.com 

Rocket Lab's growing Space Systems business positions it to provide more than launches for the space economy. It generated $189.5M in Q2, 81% of revenue; if its pending Iridium acquisition closes, it would gain a global satellite communications network. At about $51, this is one of the most compelling long-term opportunities in the space sector over 3-5 years, provided it keeps executing. Neutron's launch has slipped to 2027, and execution risks remain. x.com  x.com  x.com 

Rocket Lab's vertical integration is structurally diluting the margins that made it special. Q3 GAAP gross margin is guided to 29-31% from 36.1%, and purchase accounting from Mynaric and Motiv explains at most a third of the drop. Per management, components earn over 70% margins while satellite platforms run in the mid-30s, and the growth is in platforms. Neutron sells full-price $50-55M slots but has never flown, so its value as a second launch source remains unrealized. x.com 

Repeated Neutron delays undermine the premium on Rocket Lab stock when execution keeps slipping. The company does not live or die by Neutron, but 50x sales was unjustified; even at 26x 2027 sales, a legitimate price suggests another 50% decline. x.com  x.com 

Rocket Lab's acquisition of Iridium is the bold move management should make with a premium equity currency, buying an attractive satcom platform. It paid over 2x the per-MHz price of the EchoStar and Globalstar deals for Iridium's L-band spectrum, but gains a brand, commercial and government customers and a profitable business. Revenue roughly doubles, cutting the 2027 revenue multiple from about 37x to 25x. The valuation is still spicy and assumes execution on Neutron, satcom and integrations. … Show more

Rocket Lab's fundamentals do not yet justify buying, even after a 55% drop took it to around its 200-day moving average. It still lacks positive earnings, net income and growing free cash flow. The upside could be significant if the business executes over the next few years, but more proof of profitability is needed first; it stays on the watch list. x.com  x.com 

Rocket Lab still looks ridiculously expensive at 29 times forward sales against SpaceX at 22 times, even after a 65% fall. At 22 times, Rocket Lab would be roughly $38, and SpaceX would still be the pick. SpaceX also has better forward guidance; Rocket Lab's negative adjusted EBITDA makes sales multiples the valuation yardstick. x.com  x.com  x.com  x.com 

Investors rotating into cheaper stocks with more upside should ultimately benefit Rocket Lab and AST SpaceMobile. Both have already suffered major drawdowns. x.com 

Rocket Lab's price bets on the most optimistic version of its results a decade out while it is still losing money, so the market is pricing a story rather than the company. Narrative now earns a premium and earnings do not, as with IonQ and AI-server-labeled Dell and HPE, and one quarterly miss means exit. This can last a long time in liquid, risk-on markets, as 1999 dot-coms and 2021 SPACs showed, so a drop is not imminent; buyers now are buying how long sentiment lasts. x.com